←
Ben Prosser406 posts
Ben Prosser avatar

Ben Prosser

@Prosser_Lab

Assoc. Prof @PennMedicine | Rare-disease dad. Trying to fix hearts AND brains. Myocytes, Microtubules, Heart Failure | ASOs, RNA, NeuroDevelopmental Disorders.

◷ Joined March 2020▧ 75 Photos and videos
Rikke S. Møller avatar
⟳ Ben Prosser retweeted
Rikke S. Møller@FiladelfiaGene1·14 Oct 2024

This study, conducted in close collaboration with @curestxbp1, aimed to identify the rate & causes of early mortality in #STXBP1-related disorders. These results are important for family & prognostic counselling💜 @FrancescaFuria_ @Elegardella 👏 link.springer.com/article/10…

Ben Prosser avatar
Ben Prosser@Prosser_Lab·19 Jul 2024

In vivo, overnight VASHi was well tolerated, and improved ventricular relaxation and diastolic function in advanced HFpEF. (opinion - that's pretty cool for just targeting a microtubule PTM!) 4/5

Post attachment
Ben Prosser avatar
Ben Prosser@Prosser_Lab·19 Jul 2024

ZSF1-Obese rats capture many features of human HFpEF. Ex vivo, we found that VASH inhibition (VASHi) lowered cardiomyocyte stiffness and improved relaxation in HFpEF cardiomyocytes. 3/5

Post attachment
Ben Prosser avatar
Ben Prosser@Prosser_Lab·19 Jul 2024

Microtubule detyrosination (dTyr) is increased in human heart failure, and contributes to cardiac stiffening. We tested a new, potent small molecule inhibitor of the detyrosinase (VASH) to see if it could lower stiffness and improve function in a rat model of HFpEF. 2/5

Post attachment
Ben Prosser avatar
Ben Prosser@Prosser_Lab·3 May 2024

Happy birthday Lu! 6 years - and now standing by yourself! I have too many feelings to tweet, so I'll just say THANK YOU to everyone who has supported Lucy, or who is fighting to improve the lives of those with #raredisease. Keep going.

Post attachmentPost attachment